This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
September 11-12, 2024
Hynes Convention CentreBoston
September 11-12, 2024
Hynes Convention Centre,

Navigate the shifting biotech financing landscape by accessing strategic knowledge to simplify your route to capital and secure new partnerships

Connecting biotech leaders, investors, and large & midsize pharmaceutical companies

Biotech Leaders is part of LSX World

For the last 10 years, Biotech Leaders has been working with international life science & healthcare decision makers who are leading the next wave of industry innovation.

Our mission is to help them overcome challenges by connecting them with advisors and strategic partners that can help take their innovation from concept to market.

At the heart of the Biotech Leaders network are the founders and CEOs of the world’s most innovative drug discovery and therapeutic start-ups and SMEs. 

They are joined by leading health and life science investors from across the USA and Europe and pharma who are on the look out for new innovation, partners and advisors. 

5 Reasons to choose Biotech Leaders

Biotech Leaders @ LSX World Congress USA is America’s largest and most significant Biotech CEO gathering. No other event is exclusively designed to address all the strategic and partnering goals of  America’s Biotech CEO ecosystem. 

Biotech Leaders @ LSX World Congress USA attracts the highest quality speakers from the biggest and best large pharma and life science investment firms. Hear from global BD heads at J&J, Merck, Novo Nordisk, GSK, Eli Lily and Boehringer Ingelheim.

No other event offers access to as many highly-qualified, specialist life science investors. LSX World Congress USA will be bringing over 200 of the world’s most active investors to Boston. Fundraising? There’s no better place to be.

All biotechs, investors and pharma attendees are qualified during the registration process to ascertain their stage of development, strategic goals, therapeutic preferences, and fundraising/allocation targets. This provides absolute clarity on the issues that matter most to our attendees and allows delegates and partners to identify and target the most qualified prospects through our highly sophisticated 1-2-1 partnering system.

As well as partnering, content, showcases and exhibition, Biotech Leaders @ LSX World Congress USA offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.